Archives: Search / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015
2011 Archives
Philadelphia, PA – December 12, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its... More |
Philadelphia, PA – December 7, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the Oppenheimer 22nd Annual Healthcare Conference on... More |
Philadelphia, PA – November 10, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the Lazard Capital Markets 8th Annual Healthcare... More |
Philadelphia, PA – November 3, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported increased sales and income for the fiscal 2012 first quarter ended September 30, 2011. Net... More |
Philadelphia, PA – October 27, 2011 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2012... More |
Philadelphia, PA – October 24, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its... More |
Philadelphia, PA – October 14, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has commenced shipping three products - Diethylpropion Tablets 25mg, Phentermine... More |
Philadelphia, PA – September 27, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) for its... More |
Philadelphia, PA – September13, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the UBS Global Life Sciences Conference on Monday,... More |
Philadelphia, PA – September 12, 2011 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that Arthur Bedrosian, the company’s president... More |
Philadelphia, PA – September 7, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2011 fourth quarter and full year ended June 30, 2011. For... More |
Philadelphia, PA – September 1, 2011 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2011... More |
Philadelphia, PA – August 16, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced the appointment of Jeffrey Farber as Vice Chairman of the Board. Farber, 50, has served as a... More |
Philadelphia, PA – August 11, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has commenced shipping of its Morphine Sulfate Oral Solution product. The company... More |
Philadelphia, PA – August 8, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced the appointment of Martin P. Galvan as chief financial officer, succeeding Keith Ruck, who... More |
Philadelphia, PA – August 2, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Keith Ruck has resigned as chief financial officer to pursue other interests. The... More |
Philadelphia, PA – July 29, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced the U.S. Food and Drug Administration (FDA) approved its Abbreviated New Drug Application... More |
Philadelphia, PA – July 20, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its... More |
Philadelphia, PA – July 18, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its... More |
Philadelphia, PA – July 5, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced the promotion of Robert Ehlinger to vice president of logistics and chief information officer.... More |
Philadelphia, PA – June 24, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s 505(b)(2) New... More |
Philadelphia, PA – June 6, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) announced today that the U.S. Food and Drug Administration (FDA) has issued a revised Prescription Drug User... More |
Ronald A. West Appointed Chairman; William Farber Named Chairman Emeritus Philadelphia, PA – June 1, 2011 – The Board of Directors of Lannett Company, Inc. (NYSE AMEX: LCI) today announced that effective July 1, 2011 Ronald A. West will become Chairman of... More |
Philadelphia, PA – May 18, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced Arthur Bedrosian, president and chief executive officer, purchased 5,000 shares of the company’s More |
1-25 26-34 |